COVID-19 Outbreak-Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 107
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease which includes emphysema, chronic bronchitis, refractory asthma, and some forms of bronchiectasis. This disease is characterized by increasing breathlessness, wheezing,....
COVID-19 Outbreak-Global Animal Antibacterial and Antibiotics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 111
Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms,....
COVID-19 Outbreak-Global Fish Vaccine Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 123
The Fish Vaccine market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this....
COVID-19 Outbreak-Global Autism Disorder & Treatment Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 129
The Autism Disorder & Treatment market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak....
COVID-19 Outbreak-Global Moxifloxacin Hcl (Cas 186826-86-8) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 130
The Moxifloxacin Hcl (Cas 186826-86-8) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak....